Global strategic partner in healthcare, Avalere Health, is proud to announce the appointment of Amar Urhekar as its new Chief ...

Almac Clinical Technologies is a global provider of Interactive Response Technology (IRT) and expert consultancy for the biopharmaceutical industry, empowering trial sponsors to pro-actively manage ...

While other big pharmas have faltered, Lilly made headway in a Phase 3 trial that could provide a treatment option to replace ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

Analysts slashed their price targets for the Massachusetts biotech after ‘messy’ trial results in alopecia and eczema.

The company now says that, during a recent meeting with the FDA, the two parties agreed on some key elements for an ...

Data from Eli Lilly and AstraZeneca could help doctors decide treatment order in chronic lymphocytic leukemia. Elsewhere, ...

The findings add to evidence that the company’s drug, obicetrapib, could change the narrative surrounding a once-abandoned ...

The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...

Today, Unite Genomics announced a new partnership with a top 10 pharmaceutical company, adding to its growing list of pharma customers. The collaboration will empower Psoriasis patients to better ...

The Almac Group has today announced the release of its 2024 Sustainability Report which outlines Almac’s ongoing commitment to their people, the planet and the communities where the Group operates, ...

A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...